Hangzhou Tigermed Consulting Co., Ltd（stock symbol: 300347） is a leading Contract Research Organization (CRO) in China dedicated to providing professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality.
Headquartered in Hangzhou, Tigermed operates:
33 subsidiaries
53 offices across China and
10 overseas offices in Hong Kong (China), Taiwan (China), USA, Canada, Korea, Australia, Japan, Malaysia, Singapore, and India
over 1800 full-time staffs. Tigermed has set up international standard SOPs and serviced
300+ local and global clients in the conduct of
400+ clinical trials. Tigermed is recognized as “The Innovative CRO” in China，owning to our involvement of 50 innovative drugs.
